Chison Medical Technologies Salute del bilancio

Salute finanziaria criteri di controllo 6/6

Chison Medical Technologies ha un patrimonio netto totale di CN¥1.4B e un debito totale di CN¥0.0, che porta il suo rapporto debito/patrimonio netto a 0%. Le sue attività totali e le sue passività totali sono rispettivamente CN¥1.6B e CN¥210.9M. L'EBIT di Chison Medical Technologies è CN¥76.2M rendendo il suo rapporto di copertura degli interessi -2.4. Ha liquidità e investimenti a breve termine pari a CN¥1.1B.

Informazioni chiave

Rapporto debito/patrimonio netto

CN¥0

Debito

Indice di copertura degli interessi	-2.4x
Contanti	CN¥1.07b
Patrimonio netto	CN¥1.38b
Totale passività	CN¥210.95m
Totale attività	CN¥1.59b

Aggiornamenti recenti sulla salute finanziaria

Nessun aggiornamento

Recent updates

Chison Medical Technologies' (SHSE:688358) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Nov 06

The Market Lifts Chison Medical Technologies Co., Ltd. (SHSE:688358) Shares 39% But It Can Do More

Oct 08

Capital Allocation Trends At Chison Medical Technologies (SHSE:688358) Aren't Ideal

Sep 27

Chison Medical Technologies' (SHSE:688358) Solid Earnings May Rest On Weak Foundations

Apr 25

Further Upside For Chison Medical Technologies Co., Ltd. (SHSE:688358) Shares Could Introduce Price Risks After 27% Bounce

Mar 04

Analisi della posizione finanziaria

Passività a breve termine: Le attività a breve termine ( CN¥1.4B ) di 688358 superano le sue passività a breve termine ( CN¥200.4M ).

Passività a lungo termine: Le attività a breve termine di 688358 ( CN¥1.4B ) superano le sue passività a lungo termine ( CN¥10.6M ).

Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: 688358 è esente da debiti.

Riduzione del debito: 688358 non ha avuto debiti negli ultimi 5 anni.

Copertura del debito: 688358 non ha debiti, pertanto non deve essere coperto dal flusso di cassa operativo.

Copertura degli interessi: 688358 non ha debiti, pertanto la copertura dei pagamenti degli interessi non è un problema.

Chison Medical Technologies Salute del bilancio

Salute finanziaria criteri di controllo 6/6

Informazioni chiave

Aggiornamenti recenti sulla salute finanziaria

Recent updates

Chison Medical Technologies' (SHSE:688358) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Third quarter 2024 earnings released: EPS: CN¥0.15 (vs CN¥0.26 in 3Q 2023)

Investor sentiment deteriorates as stock falls 18%

The Market Lifts Chison Medical Technologies Co., Ltd. (SHSE:688358) Shares 39% But It Can Do More

New minor risk - Share price stability

Chison Medical Technologies Co., Ltd. to Report Q3, 2024 Results on Oct 31, 2024

Capital Allocation Trends At Chison Medical Technologies (SHSE:688358) Aren't Ideal

Investor sentiment improves as stock rises 19%

Second quarter 2024 earnings released: EPS: CN¥0.32 (vs CN¥0.53 in 2Q 2023)

Chison Medical Technologies Co., Ltd. to Report First Half, 2024 Results on Aug 29, 2024

Chison Medical Technologies' (SHSE:688358) Solid Earnings May Rest On Weak Foundations

First quarter 2024 earnings released: EPS: CN¥0.41 (vs CN¥0.47 in 1Q 2023)

Chison Medical Technologies Co., Ltd., Annual General Meeting, May 10, 2024

Now 21% undervalued after recent price drop

Chison Medical Technologies Co., Ltd. to Report Q1, 2024 Results on Apr 19, 2024

Investor sentiment improves as stock rises 18%

Further Upside For Chison Medical Technologies Co., Ltd. (SHSE:688358) Shares Could Introduce Price Risks After 27% Bounce

Now 23% undervalued after recent price drop

Full year 2023 earnings: EPS and revenues miss analyst expectations

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 17%

Now 20% undervalued after recent price drop

Investor sentiment improves as stock rises 17%

Third quarter 2023 earnings released: EPS: CN¥0.26 (vs CN¥0.44 in 3Q 2022)

Chison Medical Technologies Co., Ltd. (SHSE:688358) commences an Equity Buyback for CNY 20 million worth of its shares, under the authorization approved on September 12, 2023.

Second quarter 2023 earnings released: EPS: CN¥0.53 (vs CN¥0.46 in 2Q 2022)

Chison Medical Technologies Co., Ltd. to Report First Half, 2023 Results on Aug 29, 2023

Investor sentiment improves as stock rises 17%

Investor sentiment improves as stock rises 18%

Investor sentiment improves as stock rises 31%

First quarter 2023 earnings released: EPS: CN¥0.47 (vs CN¥0.22 in 1Q 2022)

Third quarter 2022 earnings released: EPS: CN¥0.44 (vs CN¥0.27 in 3Q 2021)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: CN¥0.46 (vs CN¥0.22 in 2Q 2021)

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

First quarter 2022 earnings released: EPS: CN¥0.31 (vs CN¥0.28 in 1Q 2021)

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Third quarter 2021 earnings released: EPS CN¥0.38 (vs CN¥0.33 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.31 (vs CN¥0.27 in 2Q 2020)

First quarter 2021 earnings released: EPS CN¥0.28 (vs CN¥0.22 in 1Q 2020)

Full year 2020 earnings released: EPS CN¥1.32 (vs CN¥1.70 in FY 2019)

New 90-day low: CN¥49.00

New 90-day low: CN¥54.52

New 90-day low - CN¥61.94

New 90-day low - CN¥67.90

Chison Medical Technologies Co., Ltd. to Report First Half, 2020 Results on Aug 29, 2020

Analisi della posizione finanziaria

Storia e analisi del rapporto debito/patrimonio netto

Bilancio

Scoprire le aziende sane